Insulet starts construction on $100m manufacturing plant in US

WCN Editorial Team 2 Oct 2017 NORTH AMERICA BUSINESS

US-based medical device maker Insulet has broken ground on its new $100m manufacturing facility in Acton, Massachusetts.

Spanning over 350,000 sq ft of area on a 26-acre site in Acton, the new medical device factory will provide additional manufacturing capabilities closer to Insulet’s large and growing US customer base.

Upon becoming operational in 2019, the new facility is expected to create hundreds of local manufacturing jobs.

Additionally, the new US manufacturing operation will drive operating efficiencies while boosting productivity.

Massachusetts governor Charlie Baker said: “We are excited to see Insulet’s continued growth in Massachusetts, including the manufacturing jobs and innovations that will come from this new Acton facility.

“Insulet has called the Commonwealth home for nearly 20 years, investing in our communities, providing jobs and developing technologies and products that better serve patients around the globe.”

Insulet chairman and CEO Patrick Sullivan said: “Investing in our state-of-the-art manufacturing facility allows us to increase our capacity to better support our Omnipod customers, create local jobs and further strengthen our commitment to Massachusetts.

“We are experiencing significant growth across our business, and this facility will help us achieve our long-term objectives. We are committed to providing world-class service to our Podders and improving the lives of those living with diabetes.”

With 11 websites and newsletters covering all the key areas within the construction industry, World Construction Industry Network is the leading global construction information resource. READ ABOUT US



World Construction Network | is a product of GlobalData. Copyright © 2021 GlobalData. All rights reserved.